Prognostic Value of Noninvasive Cardiovascular Testing in Patients with Stable Chest Pain: Insights from the PROMISE Trial

Myocardial Infarction

Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial

JAMA Cardiol.

Ferencik M, Mayrhofer T, Bittner DO, Emami H, Puchner SB, Lu MT2, Meyersohn NM, Ivanov AV, Adami EC, Patel MR, Mark DB, Udelson JE, Lee KL, Douglas PS, Hoffmann U

doi: 10.1001/jamacardio.

Heart, Artery and Coronary Diseases

Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease: Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial

JAMA Cardiol.

Lowenstern A, Alexander KP, Hill CL, Alhanti B, Pellikka PA, Nanna MG, Mehta RH, Cooper LS, Bullock-Palmer RP, Hoffmann U, Douglas PS

doi: 10.1001/jamacardio.2019.4973.

Heart, Artery and Coronary Diseases

Clinical and Economic Implications of Inconclusive Noninvasive Test Results in Stable Patients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial

Circ Cardiovasc Imaging.

Goyal A, Pagidipati N, Hill CL, Alhanti B, Udelson JE, Picard MH, Pellikka PA, Hoffmann U, Mark DB, Douglas PS

doi: 10.1161/CIRCIMAGING.

Heart, Artery and Coronary DiseasesMyocardial Infarction

The Prognostic Value of Coronary Artery Calcium in the PROMISE Study

Circulation.

Budoff MJ, Mayrhofer T, Ferencik M, Bittner DO, Lee KL, Lu MT, Coles A, Jang JJ, Krishnam MS, Douglas PS, Hoffmann U; PROMISE Investigators

doi: 10.1161/

Heart, Artery and Coronary Diseases

Clinical Effectiveness of Cardiac Noninvasive Diagnostic Testing in Outpatients Evaluated for Stable Coronary Artery Disease

J Am Heart Assoc.

Roifman I, Sivaswamy A, Chu A, Austin PC, Ko DT, Douglas PS, Wijeysundera HC

doi: 10.1161/JAHA.119.015724.

Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases

Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

Eur Heart J.

Vidal-Petiot E, Stebbins A, Chiswell K, Ardissino D, Aylward PE, Cannon CP, Ramos Corrales MA, Held C, López-Sendón JL, Stewart Lars Wallentin RAH, White HD, Steg PG

Cardiovascular Risk and Diseases

Prognostic Value of the CHADS2 Score for Adverse Cardiovascular Events in Coronary Artery Disease Patients Without Atrial Fibrillation-A Multi-Center Observational Cohort Study

J Am Heart Assoc.

Tabata N, Yamamoto E, Hokimoto S, Yamashita T, Sueta D, Takashio S, Arima Y, Izumiya Y, Kojima S, Kaikita K, Matsui K, Fujimoto K, Sakamoto K, Shimomura H, Tsunoda R, Hirose T, Nakamura N, Sakaino N, Nakamura S, Yamamoto N, Matsumura T, Kajiwara I, Koide S, Sakamoto T, Nakao K, Oshima S, Tsujita K; Kumamoto Intervention Conference Study (KICS) Investigators

doi: 10.1161/JAHA.117.006355.

Cardiovascular Risk and Diseases

Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial

Eur Heart J.

de Vries TI, Eikelboom JW, Bosch J, Westerink J, Dorresteijn JAN, Alings M, Dyal L, Berkowitz SD, van der Graaf Y, Fox KAA, Visseren FLJ

doi: 10.1093/eurheartj/ehz404.

Heart, Artery and Coronary DiseasesMyocardial InfarctionTherapy and Intervention

Clinical Outcomes Using Coronary CT Angiography and FFRCT-Guided Management of Stable Chest Pain Patients

J Am Coll Cardiol.

Nørgaard BL, Terkelsen CJ, Mathiassen ON, Grove EL, Bøtker HE, Parner E, Leipsic J, Steffensen FH, Riis AH, Pedersen K, Christiansen EH, Mæng M, Krusell LR, Kristensen SD, Eftekhari A, Jakobsen L, Jensen JM

doi: 10.1016/j.jacc.2018.07.043.

Related content

Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain: A Secondary Analysis of the PROMISE Randomized Clinical Trial

Age-Related Differences in the Noninvasive Evaluation for Possible Coronary Artery Disease: Insights From the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) Trial

Clinical and Economic Implications of Inconclusive Noninvasive Test Results in Stable Patients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial

The Prognostic Value of Coronary Artery Calcium in the PROMISE Study

Clinical Effectiveness of Cardiac Noninvasive Diagnostic Testing in Outpatients Evaluated for Stable Coronary Artery Disease

Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial

Prognostic Value of the CHADS2 Score for Adverse Cardiovascular Events in Coronary Artery Disease Patients Without Atrial Fibrillation-A Multi-Center Observational Cohort Study

Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial

Clinical Outcomes Using Coronary CT Angiography and FFRCT-Guided Management of Stable Chest Pain Patients